January 12, 2001
FY 2000 fourth-quarter results
A quarterly status report of hospital performance
Financial overview: The MGH finished fiscal year 2000 with strong financial results, reporting an operating gain of $49.3 million for FY'00. These results were a signficant improvement over last year when the MGH reported a loss. The hsopital had very strong volume in the final quarter, resulting in an increased net patient service revenue that was better than budget, with a $54.1 million variance. Expense growth was kept at a reasonable level given the amoung of additional volume.
Admissions in the final quarter remained strong, favorable by 2,412, while observation stays were 1,198 below budget.
Admissions |
|
| FY '00 actual: | 40,747 |
| FY '00 budgeted: | 38,335 |
| FY '99 actual: | 37,569 |
| Patient Days | 241,566 |
| Inpatient Surgeries | 17,601 |
| Births | 3,096 |
Length of stay (LOS) remained steady at 5.93 days, compared with a budget of 5.90 days. Although LOS remains slightly above budget, much progress has been made in reducing LOS from last year, and it continues to be a high priority for the hospital.
Length of stay |
Days |
| FY '00 actual: | 5.93 |
| FY '00 budgeted: | 5.90 |
| FY '99 actual: | 6.15 |
Average daily census was above budget by 42.
Average daily census |
|
| FY '00 actual: | 660 |
| Average beds | 855 |
| Occupancy rate | 77% |
| FY '00 budgeted | 618 |
| FY '99 actual | 633 |
Outpatient visits increased by 5.2 percent over the previous year, with 754,246 outpatient visits.
Outpatient visits |
|
| FY '00 actual: | 754,246 |
| Clinic visits | 406,911 |
| Health Center visits | 276,085 |
| Emergency visits | 71,250 |
| FY '00 budgeted: | 719,136 |
| FY '99 actual: | 711,443 |
| Outpatient Surgeries | 13,852 |
|
|
| FY '00 actual: | 5,388 |
| FY '00 budgeted: | 6,586 |
| FY '99 actual: | 6,891 |
| Chemotherapy infusion | 716 |
| Routine post-proceedure recovery | 1,707 |
General Hospital financial statement (in millions)
| YTD Actual | Variance to Budget | FY 1999 | |
| Net Patient Revenue | 808.7 | 54.1 | 709.0 |
| Research Revenue | 265.7 | 14.5 | 236.7 |
| Other Operating Revenue | 77.3 | 8.9 | 70.0 |
| Total Revenue | 1,151.7 | 77.5 | 1,015.7 |
| Salary and Benefits | 427.9 | (19.3) | 398.3 |
| Supplies and Outside Services | 262.1 | (28.6) | 227.5 |
| Outside Operating Expenses | 236.0 | 5.4 | 231.1 |
| Direct Research Expenses | 187.3 | (9.9) | 165.0 |
| Total Expenses | 1,113.3 | (52.4) | 1,021.9 |
| Current Operating Gain/(Loss) | 38.3 | 25.1 | (6.2) |
| Restructuring Charges | 0.0 | 0.0 | (3.8) |
| Prior Year Adjustments | 11.0 | 0.0 | 13.1 |
| Gain/(Loss) from Operations | 49.3 | 25.1 | 3.1 |
Non-Operating Gains/(Losses) |
40.2 |
26.2 |
6.0 |
| Net Gain/(Loss) | 89.6 | 51.3 | 9.1 |
Return to the January 12 table of contents